small molecule

DEXMEDETOMIDINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity

CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand name	DEXMEDETOMIDINE HYDROCHLORIDE
Active ingredient	DEXMEDETOMIDINE HYDROCHLORIDE
Strength	EQ 80MCG BASE/20ML (EQ 4MCG BASE/ML)
Dosage form	INJECTABLE
Route	INJECTION
Modality	Small molecule
FDA approval	November 2018
Marketing status	RX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.